Rak pluća (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rak pluća" in Serbian language version.

refsWebsite

Global rank Serbian rank

98nih.gov

4^th place

8^th place

71doi.org

2^nd place

4^th place

13archive.org

6^th place

5^th place

12web.archive.org

1^st place

5cancer.gov

1,684^th place

703^rd place

5oxfordjournals.org

1,389^th place

438^th place

4wiley.com

222^nd place

155^th place

3who.int

195^th place

154^th place

2aafp.org

1,916^th place

2,288^th place

2iarc.fr

4,025^th place

2,629^th place

2chestpubs.org

low place

2bbc.co.uk

8^th place

16^th place

2ascopubs.org

low place

2worldcat.org

5^th place

12^th place

1merck.com

6,464^th place

4,185^th place

1surgeongeneral.gov

low place

1ojrd.com

low place

1nature.com

234^th place

287^th place

1ox.ac.uk

613^th place

779^th place

1druglibrary.org

low place

1cdc.gov

218^th place

138^th place

1ersjournals.com

low place

1obpr.gov.au

low place

1epa.gov

882^nd place

756^th place

1google.ca

838^th place

391^st place

1nejm.org

2,374^th place

2,649^th place

1rsnajnls.org

low place

1atcs.jp

low place

1un.org

97^th place

49^th place

1jst.go.jp

1,903^rd place

4,033^rd place

1atsjournals.org

low place

1bmj.com

1,226^th place

856^th place

1vpci.org.in

low place

1smokinglungs.com

low place

aafp.org

O'Reilly, KM; Mclaughlin AM; et al. (2007). „Asbestos-related lung disease”. American Family Physician. 75 (5): 683—688. PMID 17375514. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.
Collins, LG; Haines C; et al. (2007). „Lung cancer: diagnosis and management”. American Family Physician. American Academy of Family Physicians. 75 (1): 56—63. PMID 17225705. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.

archive.org

Alberg AJ, Samet JM (2010). „Chapter 46”. Murray & Nadel's Textbook of Respiratory Medicine (5th изд.). Saunders Elsevier. ISBN 978-1-4160-4710-0.
Greene, Frederick L. (2002). AJCC cancer staging manual. Berlin: Springer-Verlag. ISBN 978-0-387-95271-0.
Sood, A (децембар 2012). „Indoor fuel exposure and the lung in both developing and developed countries: an update.”. Clinics in chest medicine. 33 (4): 649—65. PMID 23153607.
Kern JA, McLennan G (2008). Fishman's Pulmonary Diseases and Disorders (4th изд.). McGraw-Hill. стр. 1802. ISBN 978-0-07-145739-2.
Fong, KM; Sekido Y; et al. (2003). „Lung cancer • 9: Molecular biology of lung cancer: clinical implications”. Thorax. BMJ Publishing Group Ltd. 58 (10): 892—900. PMC 1746489 . PMID 14514947. doi:10.1136/thorax.58.10.892.
Salgia, R; Skarin AT (1998). „Molecular abnormalities in lung cancer”. Journal of Clinical Oncology. 16 (3): 1207—1217. PMID 9508209.
Jaklitsch, MT; Jacobson FL; et al. (jul 2012). „The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups”. Journal of Thoracic and Cardiovascular Surgery. 144 (1): 33—38. PMID 22710039. doi:10.1016/j.jtcvs.2012.05.060.
Ferrell, B; Koczywas M; et al. (april 2011). „Palliative care in lung cancer”. Surgical Clinics of North America. 91 (2): 403—417. PMID 21419260. doi:10.1016/j.suc.2010.12.003.
Mehra R, Treat J (2008). Fishman's Pulmonary Diseases and Disorders (4th изд.). McGraw-Hill. стр. 1876. ISBN 978-0-07-145739-2.
British Medical Journal (2005). Clinical evidence concise : the international resource of the best available evidence for effective health care. London: BMJ Publishing Group. стр. 486-488. ISBN 978-1-905545-00-1. ISSN 1475-9225.
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC 14783544. , navedeno u Spiro SG, Silvestri GA (2005). „One hundred years of lung cancer”. American Journal of Respiratory and Critical Care Medicine. 172 (5): 523—529. PMID 15961694. doi:10.1164/rccm.200504-531OE.
Greaves, M (2000). Cancer: the Evolutionary Legacy. Oxford University Press. стр. 196—197. ISBN 978-0-19-262835-0.
Greenberg, M; Selikoff IJ (1993). „Lung cancer in the Schneeberg mines: a reappraisal of the data reported by Harting and Hesse in 1879”. Annals of Occupational Hygiene. 37 (1): 5—14. PMID 8460878.

ascopubs.org

jco.ascopubs.org

Fairchild, A; Harris K; et al. (avgust 2008). „Palliative thoracic radiotherapy for lung cancer: a systematic review”. Journal of Clinical Oncology. 26 (24): 4001—4011. PMID 18711191. doi:10.1200/JCO.2007.15.3312.
Horn, L; Johnson DH (2008). „Evarts A. Graham and the first pneumonectomy for lung cancer”. Journal of Clinical Oncology. 26 (19): 3268—3275. PMID 18591561. doi:10.1200/JCO.2008.16.8260. Архивирано из оригинала 17. 03. 2020. г. Приступљено 06. 07. 2013.

atcs.jp

Rami-Porta, R; Crowley JJ; Goldstraw P (2009). „The revised TNM staging system for lung cancer” (PDF). Annals of Thoracic and Cardiovascular Surgery. 15 (1): 4—9. PMID 19262443.

atsjournals.org

ajrccm.atsjournals.org

Slatore, CG; Au DH; Gould MK (novembar 2010). „An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes”. American Journal of Respiratory and Critical Care Medicine. 182 (9): 1195—1205. PMID 21041563. doi:10.1164/rccm.2009-038ST.

bbc.co.uk

news.bbc.co.uk

Pandey, G (2005). „Bhutan's smokers face public ban”. BBC. Приступљено 7. 9. 2007.
Pandey, G (2. 10. 2008). „Indian ban on smoking in public”. BBC. Приступљено 25. 4. 2012.

bmj.com

tobaccocontrol.bmj.com

Lum, KL; Polansky JR; et al. (2008). „Signed, sealed and delivered: "big tobacco" in Hollywood, 1927–1951”. Tobacco Control. 17 (5): 313—323. PMC 2602591 . PMID 18818225. doi:10.1136/tc.2008.025445.

cancer.gov

seer.cancer.gov

SEER data (SEER.cancer.gov)Median Age of Cancer Patients at Diagnosis 2002-2003
SEER data (SEER.cancer.gov)Median Age of Cancer Patients at Death 2002-2006
National Cancer Institute; SEER stat fact sheets: Lung and Bronchus. Surveillance Epidemiology and End Results. 2010 [1]

cancer.gov

„Non-Small Cell Lung Cancer Treatment”. PDQ for Health Professionals. National Cancer Institute. Приступљено 22. 11. 2008.
„Small Cell Lung Cancer Treatment”. PDQ for Health Professionals. National Cancer Institute. 2012. Приступљено 16. 5. 2012.

cdc.gov

California Environmental Protection Agency (1997). „Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency”. Tobacco Control. 6 (4): 346—353. PMC 1759599 . PMID 9583639. doi:10.1136/tc.6.4.346.
* CDC (2001). Centers for Disease Control and Prevention (CDC). „State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000”. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC. 50 (49): 1101—1106. PMID 11794619.

chestpubs.org

chestjournal.chestpubs.org

Alberg, AJ; Samet JM (2007). „Epidemiology of lung cancer”. Chest. American College of Chest Physicians. 132 (S3): 29S—55S. PMID 17873159. doi:10.1378/chest.07-1347. Архивирано из оригинала 29. 03. 2020. г. Приступљено 08. 02. 2014.
Simon GR, Turrisi A (septembar 2007). „Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. Chest. 132 (3 Suppl): 324S—339S. PMID 17873178. doi:10.1378/chest.07-1385.

doi.org

Thun, MJ; Hannan LM; Adams-Campbell LL; et al. (2008). „Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies”. PLoS Medicine. 5 (9): e185. PMC 2531137 . PMID 18788891. doi:10.1371/journal.pmed.0050185.
Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.
Honnorat, J; Antoine JC (2007). „Paraneoplastic neurological syndromes”. Orphanet Journal of Rare Diseases. BioMed Central. 2 (1): 22. PMC 1868710 . PMID 17480225. doi:10.1186/1750-1172-2-22.
Biesalski, HK; Bueno de Mesquita B; et al. (1998). „European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel”. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence. 48 (3): 167—176; discussion 164—166. PMID 9594919. doi:10.3322/canjclin.48.3.167.
Hecht, S (2003). „Tobacco carcinogens, their biomarkers and tobacco-induced cancer”. Nature Reviews. Cancer. Nature Publishing Group. 3 (10): 733—744. PMID 14570033. doi:10.1038/nrc1190.
Sopori, M (2002). „Effects of cigarette smoke on the immune system”. Nature Reviews. Immunology. 2 (5): 372—7. PMID 12033743. doi:10.1038/nri803.
California Environmental Protection Agency (1997). „Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency”. Tobacco Control. 6 (4): 346—353. PMC 1759599 . PMID 9583639. doi:10.1136/tc.6.4.346.
* CDC (2001). Centers for Disease Control and Prevention (CDC). „State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000”. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC. 50 (49): 1101—1106. PMID 11794619.
Alberg, AJ; Samet JM (2007). „Epidemiology of lung cancer”. Chest. American College of Chest Physicians. 132 (S3): 29S—55S. PMID 17873159. doi:10.1378/chest.07-1347. Архивирано из оригинала 29. 03. 2020. г. Приступљено 08. 02. 2014.
Jaakkola, MS; Jaakkola JJ (2006). „Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention”. European Respiratory Journal. 28 (2): 397—408. PMID 16880370. doi:10.1183/09031936.06.00001306.
Parkin, DM (2011). „Tobacco—attributable cancer burden in the UK in 2010”. British Journal of Cancer. 105 (Suppl. 2): S6—S13. PMC 3252064 . PMID 22158323. doi:10.1038/bjc.2011.475.
Taylor, R; Najafi F; Dobson A (2007). „Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent”. International Journal of Epidemiology. 36 (5): 1048—1059. PMID 17690135. doi:10.1093/ije/dym158.
Schick, S; Glantz S (2005). „Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke”. Tobacco Control. 14 (6): 396—404. PMC 1748121 . PMID 16319363. doi:10.1136/tc.2005.011288.
Schmid K, Kuwert T, Drexler H (2010). „Radon in Indoor Spaces: An Underestimated Risk Factor for Lung Cancer in Environmental Medicine”. Dtsch Arztebl Int. 107 (11): 181—6. PMC 2853156 . PMID 20386676. doi:10.3238/arztebl.2010.0181.
Fong, KM; Sekido Y; et al. (2003). „Lung cancer • 9: Molecular biology of lung cancer: clinical implications”. Thorax. BMJ Publishing Group Ltd. 58 (10): 892—900. PMC 1746489 . PMID 14514947. doi:10.1136/thorax.58.10.892.
Herbst, RS; Heymach JV; Lippman SM (2008). „Lung cancer”. New England Journal of Medicine. 359 (13): 1367—1380. PMID 18815398. doi:10.1056/NEJMra0802714. Архивирано из оригинала 28. 09. 2008. г. Приступљено 06. 07. 2013.
Aviel-Ronen, S; Blackhall FH; et al. (2006). „K-ras mutations in non-small-cell lung carcinoma: a review”. Clinical Lung Cancer. Cancer Information Group. 8 (1): 30—38. PMID 16870043. doi:10.3816/CLC.2006.n.030.
Devereux, TR; Taylor JA; Barrett JC (1996). „Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors”. Chest. American College of Chest Physicians. 109 (Suppl 3): 14S—19S. PMID 8598134. doi:10.1378/chest.109.3_Supplement.14S.
Subramanian, J; Govindan R (2007). „Lung cancer in never smokers: a review”. Journal of Clinical Oncology. American Society of Clinical Oncology. 25 (5): 561—570. PMID 17290066. doi:10.1200/JCO.2006.06.8015.
Raz, DJ; He B; et al. (2006). „Bronchioloalveolar carcinoma: a review”. Clinical Lung Cancer. 7 (5): 313—322. PMID 16640802. doi:10.3816/CLC.2006.n.012.
Rosti, G; Bevilacqua G; et al. (2006). „Small cell lung cancer”. Annals of Oncology. 17 (Suppl. 2): 5—10. PMID 16608983. doi:10.1093/annonc/mdj910.
McNabola, A; Gill LW (2009). „The control of environmental tobacco smoke: a policy review”. International Journal of Environmental Research and Public Health. 6 (2): 741—758. PMC 2672352 . PMID 19440413. doi:10.3390/ijerph6020741.
Fritz, H; Kennedy D; et al. (2011). „Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis”. PLoS ONE. 6 (6): e21107. PMC 3124481 . PMID 21738614. doi:10.1371/journal.pone.0021107.
Herr, C; Greulich T; et al. (mart 2011). „The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer”. Respiratory Research. 12 (1): 31. PMC 3071319 . PMID 21418564. doi:10.1186/1465-9921-12-31.
Key, TJ (januar 2011). „Fruit and vegetables and cancer risk”. British Journal of Cancer. 104 (1): 6—11. PMC 3039795 . PMID 21119663. doi:10.1038/sj.bjc.6606032.
Manser, RL; Irving LB; et al. (2004). „Screening for lung cancer”. Cochrane Database of Systematic Reviews (1): CD001991. PMID 14973979. doi:10.1002/14651858.CD001991.pub2.
Jaklitsch, MT; Jacobson FL; et al. (jul 2012). „The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups”. Journal of Thoracic and Cardiovascular Surgery. 144 (1): 33—38. PMID 22710039. doi:10.1016/j.jtcvs.2012.05.060.
Bach, PB; Mirkin JN; et al. (jun 2012). „Benefits and harms of CT screening for lung cancer: a systematic review”. JAMA: the Journal of the American Medical Association. 307 (22): 2418—2429. PMID 22610500. doi:10.1001/jama.2012.5521.
Boiselle, PM (20. 3. 2013). „Computed tomography screening for lung cancer.”. JAMA: the Journal of the American Medical Association. 309 (11): 1163—70. PMID 23512063. doi:10.1001/jama.2012.216988.
Bach PB; Mirkin JN; Oliver TK; et al. (jun 2012). „Benefits and harms of CT screening for lung cancer: a systematic review”. JAMA. 307 (22): 2418—29. PMID 22610500. doi:10.1001/jama.2012.5521.
Aberle, DR; Abtin, F; Brown, K (10. 3. 2013). „Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.”. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31 (8): 1002—8. PMID 23401434. doi:10.1200/JCO.2012.43.3110.
Ferrell, B; Koczywas M; et al. (april 2011). „Palliative care in lung cancer”. Surgical Clinics of North America. 91 (2): 403—417. PMID 21419260. doi:10.1016/j.suc.2010.12.003.
Odell, DD; Kent MS; Fernando HC (proleće 2010). „Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer”. Seminars in Thoracic and Cardiovascular Surgery. 22 (1): 32—37. PMID 20813314. doi:10.1053/j.semtcvs.2010.04.003.
Rueth, NM; Andrade RS (jun 2010). „Is VATS lobectomy better: perioperatively, biologically and oncologically?”. Annals of Thoracic Surgery. 89 (6): S2107—S2111. PMID 20493991. doi:10.1016/j.athoracsur.2010.03.020.
Simon GR, Turrisi A (septembar 2007). „Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. Chest. 132 (3 Suppl): 324S—339S. PMID 17873178. doi:10.1378/chest.07-1385.
Goldstein, SD; Yang SC (oktobar 2011). „Role of surgery in small cell lung cancer”. Surgical Oncology Clinics of North America. 20 (4): 769—777. PMID 21986271. doi:10.1016/j.soc.2011.08.001.
Hatton, MQ; Martin JE (jun 2010). „Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions”. Clinical Oncology (Royal College of Radiologists). 22 (5): 356—364. PMID 20399629. doi:10.1016/j.clon.2010.03.010.
PORT Meta-analysis Trialists Group (2005). Rydzewska, Larysa, ур. „Postoperative radiotherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD002142. PMID 15846628. doi:10.1002/14651858.CD002142.pub2. Архивирано из оригинала 9. 2. 2010. г. Приступљено 6. 7. 2013.
Le Péchoux, C (2011). „Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data”. Oncologist. 16 (5): 672—681. PMC 3228187 . PMID 21378080. doi:10.1634/theoncologist.2010-0150.
Cardona, AF; Reveiz L; et al. (april 2008). „Palliative endobronchial brachytherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD004284. PMID 18425900. doi:10.1002/14651858.CD004284.pub2.
Paumier, A; Cuenca X; et al. (jun 2011). „Prophylactic cranial irradiation in lung cancer”. Cancer Treatment Reviews. 37 (4): 261—265. PMID 20934256. doi:10.1016/j.ctrv.2010.08.009.
Girard, N; Mornex F (oktobar 2011). „Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update”. Cancer Radiothérapie. 15 (6–7): 522—526. PMID 21889901. doi:10.1016/j.canrad.2011.07.241.
Fairchild, A; Harris K; et al. (avgust 2008). „Palliative thoracic radiotherapy for lung cancer: a systematic review”. Journal of Clinical Oncology. 26 (24): 4001—4011. PMID 18711191. doi:10.1200/JCO.2007.15.3312.
Azim, HA; Ganti AK (2007). „Treatment options for relapsed small-cell lung cancer”. Anticancer drugs. 18 (3): 255—261. PMID 17264756. doi:10.1097/CAD.0b013e328011a547.
MacCallum, C; Gillenwater HH (2006). „Second-line treatment of small-cell lung cancer”. Current Oncology Reports. 8 (4): 258—264. PMID 17254525. doi:10.1007/s11912-006-0030-8.
NSCLC Meta-Analyses Collaborative Group (2008). „Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials”. J. Clin. Oncol. 26 (28): 4617—25. PMC 2653127 . PMID 18678835. doi:10.1200/JCO.2008.17.7162.
Clegg, A; Scott DA; et al. (2002). „Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review”. Thorax. BMJ Publishing Group. 57 (1): 20—28. PMC 1746188 . PMID 11809985. doi:10.1136/thorax.57.1.20.
Fuld AD, Dragnev KH, Rigas JR (jun 2010). „Pemetrexed in advanced non-small-cell lung cancer”. Expert Opin Pharmacother. 11 (8): 1387—402. PMID 20446853. doi:10.1517/14656566.2010.482560.
Carbone, DP; Felip E (2011). „Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms”. Clinical Lung Cancer. 12 (5): 261—271. PMID 21831720. doi:10.1016/j.cllc.2011.06.002.
Le Chevalier, T (2010). „Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?”. Annals of Oncology. 21 (Suppl. 7): vii196—198. PMID 20943614. doi:10.1093/annonc/mdq376.
Horn, L; Sandler AB; et al. (2007). „The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer”. Journal of Thoracic Oncology. 2 (5): 377—383. PMID 17473651. doi:10.1097/01.JTO.0000268669.64625.bb.
Wakelee, HA; Schiller JH; Gandara DR (2006). „Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial”. Clinical Lung Cancer. Cancer Information Group. 8 (1): 18—21. PMID 16870041. doi:10.3816/CLC.2006.n.028.
Kelley AS, Meier DE (2010). „Palliative care–a shifting paradigm”. New England Journal of Medicine. 363 (8): 781—2. PMID 20818881. doi:10.1056/NEJMe1004139.
Souquet PJ, Chauvin F, Boissel JP, Bernard JP (1995). „Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer”. Lung Cancer. 12 Suppl 1: S147—54. PMID 7551923. doi:10.1016/0169-5002(95)00430-9.
Slatore, CG; Au DH; Gould MK (novembar 2010). „An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes”. American Journal of Respiratory and Critical Care Medicine. 182 (9): 1195—1205. PMID 21041563. doi:10.1164/rccm.2009-038ST.
Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.
Jemal A; Tiwari RC; Murray T; et al. (2004). „Cancer statistics, 2004”. CA: a Cancer Journal for Clinicians. 54 (1): 8—29. PMID 14974761. doi:10.3322/canjclin.54.1.8.
Proctor, RN (2012). „The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll”. Tobacco Control. 21 (2): 87—91. PMID 22345227. doi:10.1136/tobaccocontrol-2011-050338.
Lum, KL; Polansky JR; et al. (2008). „Signed, sealed and delivered: "big tobacco" in Hollywood, 1927–1951”. Tobacco Control. 17 (5): 313—323. PMC 2602591 . PMID 18818225. doi:10.1136/tc.2008.025445.
Lovato, C; Watts A; Stead LF (oktobar 2011). „Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours”. Cochrane Database of Systematic Reviews (10): CD003439. PMID 21975739. doi:10.1002/14651858.CD003439.pub2.
Zhang, J; Ou JX; Bai CX (novembar 2011). „Tobacco smoking in China: prevalence, disease burden, challenges and future strategies”. Respirology. 16 (8): 1165—1172. PMID 21910781. doi:10.1111/j.1440-1843.2011.02062.x.
Charloux, A; Quoix E; et al. (1997). „The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma”. International Journal of Epidemiology. 26 (1): 14—23. PMID 9126499. doi:10.1093/ije/26.1.14.
Kadara, H; Kabbout M; Wistuba II (2012). „Pulmonary adenocarcinoma: a renewed entity in 2011”. Respirology. 17 (1): 50—65. PMID 22040022. doi:10.1111/j.1440-1843.2011.02095.x.
Witschi, H (2001). „A short history of lung cancer”. Toxicological Sciences. 64 (1): 4—6. PMID 11606795. doi:10.1093/toxsci/64.1.4.
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC 14783544. , navedeno u Spiro SG, Silvestri GA (2005). „One hundred years of lung cancer”. American Journal of Respiratory and Critical Care Medicine. 172 (5): 523—529. PMID 15961694. doi:10.1164/rccm.200504-531OE.
Doll, R; Hill AB (1956). „Lung Cancer and Other Causes of Death in Relation to Smoking”. British Medical Journal. 2 (5001): 1071—1081. PMC 2035864 . PMID 13364389. doi:10.1136/bmj.2.5001.1071.
Samet, JM (2011). „Radiation and cancer risk: a continuing challenge for epidemiologists”. Environmental Health. 10 (Suppl. 1): S4. PMC 3073196 . PMID 21489214. doi:10.1186/1476-069X-10-S1-S4.
Horn, L; Johnson DH (2008). „Evarts A. Graham and the first pneumonectomy for lung cancer”. Journal of Clinical Oncology. 26 (19): 3268—3275. PMID 18591561. doi:10.1200/JCO.2008.16.8260. Архивирано из оригинала 17. 03. 2020. г. Приступљено 06. 07. 2013.
Edwards, AT (1946). „Carcinoma of the Bronchus”. Thorax. 1 (1): 1—25. PMC 1018207 . PMID 20986395. doi:10.1136/thx.1.1.1.
Saunders, M; Dische S; et al. (1997). „Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial”. Lancet. Elsevier. 350 (9072): 161—165. PMID 9250182. doi:10.1016/S0140-6736(97)06305-8.
Lennox, SC; Flavell G; et al. (1968). „Results of resection for oat-cell carcinoma of the lung”. Lancet. Elsevier. 2 (7575): 925—927. PMID 4176258. doi:10.1016/S0140-6736(68)91163-X.
Miller, AB; Fox W; Tall R (1969). „Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus”. Lancet. Elsevier. 2 (7619): 501—505. PMID 4184834. doi:10.1016/S0140-6736(69)90212-8.

druglibrary.org

California Environmental Protection Agency (1997). „Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency”. Tobacco Control. 6 (4): 346—353. PMC 1759599 . PMID 9583639. doi:10.1136/tc.6.4.346.
* CDC (2001). Centers for Disease Control and Prevention (CDC). „State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000”. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC. 50 (49): 1101—1106. PMID 11794619.

epa.gov

EPA (2006). „Radiation information: radon”. EPA. Приступљено 11. 8. 2007.

ersjournals.com

erj.ersjournals.com

Jaakkola, MS; Jaakkola JJ (2006). „Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention”. European Respiratory Journal. 28 (2): 397—408. PMID 16880370. doi:10.1183/09031936.06.00001306.

google.ca

books.google.ca

Dudley, Joel (2013). Exploring Personal Genomics. Oxford University Press. стр. 25—. ISBN 9780199644483.

iarc.fr

monographs.iarc.fr

„Tobacco Smoke and Involuntary Smoking” (PDF). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. WHO International Agency for Research on Cancer. 83. 2002. „There is sufficient evidence that involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) causes lung cancer in humans. [...] Involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) is carcinogenic to humans (Group 1).”
Cogliano, VJ; Baan, R; et al. (2011. 12. 21). „Preventable exposures associated with human cancers.” (PDF). Journal of the National Cancer Institute. 103 (24): 1827—39. PMID 22158127. Архивирано из оригинала (PDF) 20. 09. 2012. г. Приступљено 08. 02. 2014. Проверите вредност парамет(а)ра за датум: |date= (помоћ)

jst.go.jp

jstage.jst.go.jp

Ikushima, H (februar 2010). „Radiation therapy: state of the art and the future”. Journal of Medical Investigation. 57 (1–2): 1—11. PMID 20299738. ^{[мртва веза]}

merck.com

„Lung Carcinoma: Tumors of the Lungs”. Merck Manual Professional Edition, Online edition. Приступљено 15. 8. 2007.

nature.com

Hecht, S (2003). „Tobacco carcinogens, their biomarkers and tobacco-induced cancer”. Nature Reviews. Cancer. Nature Publishing Group. 3 (10): 733—744. PMID 14570033. doi:10.1038/nrc1190.

nejm.org

content.nejm.org

Herbst, RS; Heymach JV; Lippman SM (2008). „Lung cancer”. New England Journal of Medicine. 359 (13): 1367—1380. PMID 18815398. doi:10.1056/NEJMra0802714. Архивирано из оригинала 28. 09. 2008. г. Приступљено 06. 07. 2013.

nih.gov

ncbi.nlm.nih.gov

Thun, MJ; Hannan LM; Adams-Campbell LL; et al. (2008). „Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies”. PLoS Medicine. 5 (9): e185. PMC 2531137 . PMID 18788891. doi:10.1371/journal.pmed.0050185.
O'Reilly, KM; Mclaughlin AM; et al. (2007). „Asbestos-related lung disease”. American Family Physician. 75 (5): 683—688. PMID 17375514. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.
Collins, LG; Haines C; et al. (2007). „Lung cancer: diagnosis and management”. American Family Physician. American Academy of Family Physicians. 75 (1): 56—63. PMID 17225705. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.
Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.
Honnorat, J; Antoine JC (2007). „Paraneoplastic neurological syndromes”. Orphanet Journal of Rare Diseases. BioMed Central. 2 (1): 22. PMC 1868710 . PMID 17480225. doi:10.1186/1750-1172-2-22.
Biesalski, HK; Bueno de Mesquita B; et al. (1998). „European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel”. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence. 48 (3): 167—176; discussion 164—166. PMID 9594919. doi:10.3322/canjclin.48.3.167.
Hecht, S (2003). „Tobacco carcinogens, their biomarkers and tobacco-induced cancer”. Nature Reviews. Cancer. Nature Publishing Group. 3 (10): 733—744. PMID 14570033. doi:10.1038/nrc1190.
Sopori, M (2002). „Effects of cigarette smoke on the immune system”. Nature Reviews. Immunology. 2 (5): 372—7. PMID 12033743. doi:10.1038/nri803.
California Environmental Protection Agency (1997). „Health effects of exposure to environmental tobacco smoke. California Environmental Protection Agency”. Tobacco Control. 6 (4): 346—353. PMC 1759599 . PMID 9583639. doi:10.1136/tc.6.4.346.
* CDC (2001). Centers for Disease Control and Prevention (CDC). „State-specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke—United States, 2000”. Morbidity and Mortality Weekly Report. Atlanta, Georgia: CDC. 50 (49): 1101—1106. PMID 11794619.
Alberg, AJ; Samet JM (2007). „Epidemiology of lung cancer”. Chest. American College of Chest Physicians. 132 (S3): 29S—55S. PMID 17873159. doi:10.1378/chest.07-1347. Архивирано из оригинала 29. 03. 2020. г. Приступљено 08. 02. 2014.
Jaakkola, MS; Jaakkola JJ (2006). „Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention”. European Respiratory Journal. 28 (2): 397—408. PMID 16880370. doi:10.1183/09031936.06.00001306.
Parkin, DM (2011). „Tobacco—attributable cancer burden in the UK in 2010”. British Journal of Cancer. 105 (Suppl. 2): S6—S13. PMC 3252064 . PMID 22158323. doi:10.1038/bjc.2011.475.
Taylor, R; Najafi F; Dobson A (2007). „Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent”. International Journal of Epidemiology. 36 (5): 1048—1059. PMID 17690135. doi:10.1093/ije/dym158.
Schick, S; Glantz S (2005). „Philip Morris toxicological experiments with fresh sidestream smoke: more toxic than mainstream smoke”. Tobacco Control. 14 (6): 396—404. PMC 1748121 . PMID 16319363. doi:10.1136/tc.2005.011288.
Schmid K, Kuwert T, Drexler H (2010). „Radon in Indoor Spaces: An Underestimated Risk Factor for Lung Cancer in Environmental Medicine”. Dtsch Arztebl Int. 107 (11): 181—6. PMC 2853156 . PMID 20386676. doi:10.3238/arztebl.2010.0181.
Chen, H; Goldberg MS; Villeneuve PJ (2008). „A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases”. Reviews on Environmental Health. 23 (4): 243—297. PMID 19235364.
Clapp, RW; Jacobs MM; Loechler EL (2008). „Environmental and Occupational Causes of Cancer New Evidence, 2005–2007”. Reviews on Environmental Health. 23 (1): 1—37. PMC 2791455 . PMID 18557596.
Lim, WY; Seow, A (јануар 2012). „Biomass fuels and lung cancer.”. Respirology (Carlton, Vic.). 17 (1): 20—31. PMID 22008241.
Sood, A (децембар 2012). „Indoor fuel exposure and the lung in both developing and developed countries: an update.”. Clinics in chest medicine. 33 (4): 649—65. PMID 23153607.
Cogliano, VJ; Baan, R; et al. (2011. 12. 21). „Preventable exposures associated with human cancers.” (PDF). Journal of the National Cancer Institute. 103 (24): 1827—39. PMID 22158127. Архивирано из оригинала (PDF) 20. 09. 2012. г. Приступљено 08. 02. 2014. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Fong, KM; Sekido Y; et al. (2003). „Lung cancer • 9: Molecular biology of lung cancer: clinical implications”. Thorax. BMJ Publishing Group Ltd. 58 (10): 892—900. PMC 1746489 . PMID 14514947. doi:10.1136/thorax.58.10.892.
Salgia, R; Skarin AT (1998). „Molecular abnormalities in lung cancer”. Journal of Clinical Oncology. 16 (3): 1207—1217. PMID 9508209.
Herbst, RS; Heymach JV; Lippman SM (2008). „Lung cancer”. New England Journal of Medicine. 359 (13): 1367—1380. PMID 18815398. doi:10.1056/NEJMra0802714. Архивирано из оригинала 28. 09. 2008. г. Приступљено 06. 07. 2013.
Aviel-Ronen, S; Blackhall FH; et al. (2006). „K-ras mutations in non-small-cell lung carcinoma: a review”. Clinical Lung Cancer. Cancer Information Group. 8 (1): 30—38. PMID 16870043. doi:10.3816/CLC.2006.n.030.
Devereux, TR; Taylor JA; Barrett JC (1996). „Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors”. Chest. American College of Chest Physicians. 109 (Suppl 3): 14S—19S. PMID 8598134. doi:10.1378/chest.109.3_Supplement.14S.
Subramanian, J; Govindan R (2007). „Lung cancer in never smokers: a review”. Journal of Clinical Oncology. American Society of Clinical Oncology. 25 (5): 561—570. PMID 17290066. doi:10.1200/JCO.2006.06.8015.
Raz, DJ; He B; et al. (2006). „Bronchioloalveolar carcinoma: a review”. Clinical Lung Cancer. 7 (5): 313—322. PMID 16640802. doi:10.3816/CLC.2006.n.012.
Rosti, G; Bevilacqua G; et al. (2006). „Small cell lung cancer”. Annals of Oncology. 17 (Suppl. 2): 5—10. PMID 16608983. doi:10.1093/annonc/mdj910.
Seo, JB; Im JG; et al. (1. 3. 2001). „Atypical pulmonary metastases: spectrum of radiologic findings”. Radiographics. 21 (2): 403—417. PMID 11259704.
Tan D, Zander DS (2008). „Immunohistochemistry for Assessment of Pulmonary and Pleural Neoplasms: A Review and Update”. Int J Clin Exp Pathol. 1 (1): 19—31. PMC 2480532 . PMID 18784820.
Rami-Porta, R; Crowley JJ; Goldstraw P (2009). „The revised TNM staging system for lung cancer” (PDF). Annals of Thoracic and Cardiovascular Surgery. 15 (1): 4—9. PMID 19262443.
Goodman, GE (2002). „Lung cancer. 1: prevention of lung cancer” (PDF). Thorax. 57 (11): 994—999. PMC 1746232 . PMID 12403886.
McNabola, A; Gill LW (2009). „The control of environmental tobacco smoke: a policy review”. International Journal of Environmental Research and Public Health. 6 (2): 741—758. PMC 2672352 . PMID 19440413. doi:10.3390/ijerph6020741.
Fabricius, P; Lange P (July—September 2003). „Diet and lung cancer”. Monaldi Archives for Chest Disease. 59 (3): 207—211. PMID 15065316. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Fritz, H; Kennedy D; et al. (2011). „Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis”. PLoS ONE. 6 (6): e21107. PMC 3124481 . PMID 21738614. doi:10.1371/journal.pone.0021107.
Herr, C; Greulich T; et al. (mart 2011). „The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer”. Respiratory Research. 12 (1): 31. PMC 3071319 . PMID 21418564. doi:10.1186/1465-9921-12-31.
Key, TJ (januar 2011). „Fruit and vegetables and cancer risk”. British Journal of Cancer. 104 (1): 6—11. PMC 3039795 . PMID 21119663. doi:10.1038/sj.bjc.6606032.
Manser, RL; Irving LB; et al. (2004). „Screening for lung cancer”. Cochrane Database of Systematic Reviews (1): CD001991. PMID 14973979. doi:10.1002/14651858.CD001991.pub2.
Jaklitsch, MT; Jacobson FL; et al. (jul 2012). „The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups”. Journal of Thoracic and Cardiovascular Surgery. 144 (1): 33—38. PMID 22710039. doi:10.1016/j.jtcvs.2012.05.060.
Bach, PB; Mirkin JN; et al. (jun 2012). „Benefits and harms of CT screening for lung cancer: a systematic review”. JAMA: the Journal of the American Medical Association. 307 (22): 2418—2429. PMID 22610500. doi:10.1001/jama.2012.5521.
Boiselle, PM (20. 3. 2013). „Computed tomography screening for lung cancer.”. JAMA: the Journal of the American Medical Association. 309 (11): 1163—70. PMID 23512063. doi:10.1001/jama.2012.216988.
Bach PB; Mirkin JN; Oliver TK; et al. (jun 2012). „Benefits and harms of CT screening for lung cancer: a systematic review”. JAMA. 307 (22): 2418—29. PMID 22610500. doi:10.1001/jama.2012.5521.
Aberle, DR; Abtin, F; Brown, K (10. 3. 2013). „Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.”. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31 (8): 1002—8. PMID 23401434. doi:10.1200/JCO.2012.43.3110.
Ferrell, B; Koczywas M; et al. (april 2011). „Palliative care in lung cancer”. Surgical Clinics of North America. 91 (2): 403—417. PMID 21419260. doi:10.1016/j.suc.2010.12.003.
Odell, DD; Kent MS; Fernando HC (proleće 2010). „Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer”. Seminars in Thoracic and Cardiovascular Surgery. 22 (1): 32—37. PMID 20813314. doi:10.1053/j.semtcvs.2010.04.003.
Alam, N; Flores RM (July—September 2007). „Video-assisted thoracic surgery (VATS) lobectomy: the evidence base”. Journal of the Society of Laparoendoscopic Surgeons. 11 (3): 368—374. PMC 3015831 . PMID 17931521. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Rueth, NM; Andrade RS (jun 2010). „Is VATS lobectomy better: perioperatively, biologically and oncologically?”. Annals of Thoracic Surgery. 89 (6): S2107—S2111. PMID 20493991. doi:10.1016/j.athoracsur.2010.03.020.
Simon GR, Turrisi A (septembar 2007). „Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)”. Chest. 132 (3 Suppl): 324S—339S. PMID 17873178. doi:10.1378/chest.07-1385.
Goldstein, SD; Yang SC (oktobar 2011). „Role of surgery in small cell lung cancer”. Surgical Oncology Clinics of North America. 20 (4): 769—777. PMID 21986271. doi:10.1016/j.soc.2011.08.001.
Hatton, MQ; Martin JE (jun 2010). „Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions”. Clinical Oncology (Royal College of Radiologists). 22 (5): 356—364. PMID 20399629. doi:10.1016/j.clon.2010.03.010.
PORT Meta-analysis Trialists Group (2005). Rydzewska, Larysa, ур. „Postoperative radiotherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD002142. PMID 15846628. doi:10.1002/14651858.CD002142.pub2. Архивирано из оригинала 9. 2. 2010. г. Приступљено 6. 7. 2013.
Le Péchoux, C (2011). „Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data”. Oncologist. 16 (5): 672—681. PMC 3228187 . PMID 21378080. doi:10.1634/theoncologist.2010-0150.
Cardona, AF; Reveiz L; et al. (april 2008). „Palliative endobronchial brachytherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD004284. PMID 18425900. doi:10.1002/14651858.CD004284.pub2.
Ikushima, H (februar 2010). „Radiation therapy: state of the art and the future”. Journal of Medical Investigation. 57 (1–2): 1—11. PMID 20299738. ^{[мртва веза]}
Paumier, A; Cuenca X; et al. (jun 2011). „Prophylactic cranial irradiation in lung cancer”. Cancer Treatment Reviews. 37 (4): 261—265. PMID 20934256. doi:10.1016/j.ctrv.2010.08.009.
Girard, N; Mornex F (oktobar 2011). „Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update”. Cancer Radiothérapie. 15 (6–7): 522—526. PMID 21889901. doi:10.1016/j.canrad.2011.07.241.
Fairchild, A; Harris K; et al. (avgust 2008). „Palliative thoracic radiotherapy for lung cancer: a systematic review”. Journal of Clinical Oncology. 26 (24): 4001—4011. PMID 18711191. doi:10.1200/JCO.2007.15.3312.
Hann CL, Rudin CM (30. 11. 2008). „Management of small-cell lung cancer: incremental changes but hope for the future”. Oncology (Williston Park). 22 (13): 1486—92. PMID 19133604.
Murray, N; Turrisi AT (2006). „A review of first-line treatment for small-cell lung cancer”. Journal of Thoracic Oncology. 1 (3): 270—278. PMID 17409868.
Azim, HA; Ganti AK (2007). „Treatment options for relapsed small-cell lung cancer”. Anticancer drugs. 18 (3): 255—261. PMID 17264756. doi:10.1097/CAD.0b013e328011a547.
MacCallum, C; Gillenwater HH (2006). „Second-line treatment of small-cell lung cancer”. Current Oncology Reports. 8 (4): 258—264. PMID 17254525. doi:10.1007/s11912-006-0030-8.
NSCLC Meta-Analyses Collaborative Group (2008). „Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials”. J. Clin. Oncol. 26 (28): 4617—25. PMC 2653127 . PMID 18678835. doi:10.1200/JCO.2008.17.7162.
Clegg, A; Scott DA; et al. (2002). „Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review”. Thorax. BMJ Publishing Group. 57 (1): 20—28. PMC 1746188 . PMID 11809985. doi:10.1136/thorax.57.1.20.
Fuld AD, Dragnev KH, Rigas JR (jun 2010). „Pemetrexed in advanced non-small-cell lung cancer”. Expert Opin Pharmacother. 11 (8): 1387—402. PMID 20446853. doi:10.1517/14656566.2010.482560.
Carbone, DP; Felip E (2011). „Adjuvant therapy in non-small cell lung cancer: future treatment prospects and paradigms”. Clinical Lung Cancer. 12 (5): 261—271. PMID 21831720. doi:10.1016/j.cllc.2011.06.002.
Le Chevalier, T (2010). „Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?”. Annals of Oncology. 21 (Suppl. 7): vii196—198. PMID 20943614. doi:10.1093/annonc/mdq376.
Horn, L; Sandler AB; et al. (2007). „The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer”. Journal of Thoracic Oncology. 2 (5): 377—383. PMID 17473651. doi:10.1097/01.JTO.0000268669.64625.bb.
Wakelee, HA; Schiller JH; Gandara DR (2006). „Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial”. Clinical Lung Cancer. Cancer Information Group. 8 (1): 18—21. PMID 16870041. doi:10.3816/CLC.2006.n.028.
Kelley AS, Meier DE (2010). „Palliative care–a shifting paradigm”. New England Journal of Medicine. 363 (8): 781—2. PMID 20818881. doi:10.1056/NEJMe1004139.
Prince-Paul M (2009). „When hospice is the best option: an opportunity to redefine goals”. Oncology (Williston Park, N.Y.). 23 (4 Suppl Nurse Ed): 13—7. PMID 19856592.
Souquet PJ, Chauvin F, Boissel JP, Bernard JP (1995). „Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer”. Lung Cancer. 12 Suppl 1: S147—54. PMID 7551923. doi:10.1016/0169-5002(95)00430-9.
Sörenson S, Glimelius B, Nygren P (2001). „A systematic overview of chemotherapy effects in non-small cell lung cancer”. Acta Oncol. 40 (2–3): 327—39. PMID 11441939.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N (2001). „A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer”. Health Technol Assess. 5 (32): 1—195. PMID 12065068.
Non-Small Cell Lung Cancer Collaborative Group (2010). Burdett, Sarah, ур. „Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer”. 2 (5). PMID 20464750.
Slatore, CG; Au DH; Gould MK (novembar 2010). „An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes”. American Journal of Respiratory and Critical Care Medicine. 182 (9): 1195—1205. PMID 21041563. doi:10.1164/rccm.2009-038ST.
Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.
Jemal A; Tiwari RC; Murray T; et al. (2004). „Cancer statistics, 2004”. CA: a Cancer Journal for Clinicians. 54 (1): 8—29. PMID 14974761. doi:10.3322/canjclin.54.1.8.
Proctor, RN (2012). „The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll”. Tobacco Control. 21 (2): 87—91. PMID 22345227. doi:10.1136/tobaccocontrol-2011-050338.
Lum, KL; Polansky JR; et al. (2008). „Signed, sealed and delivered: "big tobacco" in Hollywood, 1927–1951”. Tobacco Control. 17 (5): 313—323. PMC 2602591 . PMID 18818225. doi:10.1136/tc.2008.025445.
Lovato, C; Watts A; Stead LF (oktobar 2011). „Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours”. Cochrane Database of Systematic Reviews (10): CD003439. PMID 21975739. doi:10.1002/14651858.CD003439.pub2.
Kemp, FB (2009). „Smoke free policies in Europe. An overview”. Pneumologia. 58 (3): 155—158. PMID 19817310.
Zhang, J; Ou JX; Bai CX (novembar 2011). „Tobacco smoking in China: prevalence, disease burden, challenges and future strategies”. Respirology. 16 (8): 1165—1172. PMID 21910781. doi:10.1111/j.1440-1843.2011.02062.x.
Behera, D; Balamugesh T (2004). „Lung cancer in India” (PDF). Indian Journal of Chest Diseases and Allied Sciences. 46 (4): 269—281. PMID 15515828. Архивирано из оригинала (PDF) 17. 12. 2008. г. Приступљено 06. 07. 2013.
Charloux, A; Quoix E; et al. (1997). „The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma”. International Journal of Epidemiology. 26 (1): 14—23. PMID 9126499. doi:10.1093/ije/26.1.14.
Kadara, H; Kabbout M; Wistuba II (2012). „Pulmonary adenocarcinoma: a renewed entity in 2011”. Respirology. 17 (1): 50—65. PMID 22040022. doi:10.1111/j.1440-1843.2011.02095.x.
Witschi, H (2001). „A short history of lung cancer”. Toxicological Sciences. 64 (1): 4—6. PMID 11606795. doi:10.1093/toxsci/64.1.4.
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC 14783544. , navedeno u Spiro SG, Silvestri GA (2005). „One hundred years of lung cancer”. American Journal of Respiratory and Critical Care Medicine. 172 (5): 523—529. PMID 15961694. doi:10.1164/rccm.200504-531OE.
Doll, R; Hill AB (1956). „Lung Cancer and Other Causes of Death in Relation to Smoking”. British Medical Journal. 2 (5001): 1071—1081. PMC 2035864 . PMID 13364389. doi:10.1136/bmj.2.5001.1071.
Greenberg, M; Selikoff IJ (1993). „Lung cancer in the Schneeberg mines: a reappraisal of the data reported by Harting and Hesse in 1879”. Annals of Occupational Hygiene. 37 (1): 5—14. PMID 8460878.
Samet, JM (2011). „Radiation and cancer risk: a continuing challenge for epidemiologists”. Environmental Health. 10 (Suppl. 1): S4. PMC 3073196 . PMID 21489214. doi:10.1186/1476-069X-10-S1-S4.
Horn, L; Johnson DH (2008). „Evarts A. Graham and the first pneumonectomy for lung cancer”. Journal of Clinical Oncology. 26 (19): 3268—3275. PMID 18591561. doi:10.1200/JCO.2008.16.8260. Архивирано из оригинала 17. 03. 2020. г. Приступљено 06. 07. 2013.
Edwards, AT (1946). „Carcinoma of the Bronchus”. Thorax. 1 (1): 1—25. PMC 1018207 . PMID 20986395. doi:10.1136/thx.1.1.1.
Kabela, M (1956). „Erfahrungen mit der radikalen Röntgenbestrahlung des Bronchienkrebses” [Experience with radical irradiation of bronchial cancer]. Ceskoslovenská Onkológia (на језику: German). 3 (2): 109—115. PMID 13383622.
Saunders, M; Dische S; et al. (1997). „Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial”. Lancet. Elsevier. 350 (9072): 161—165. PMID 9250182. doi:10.1016/S0140-6736(97)06305-8.
Lennox, SC; Flavell G; et al. (1968). „Results of resection for oat-cell carcinoma of the lung”. Lancet. Elsevier. 2 (7575): 925—927. PMID 4176258. doi:10.1016/S0140-6736(68)91163-X.
Miller, AB; Fox W; Tall R (1969). „Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus”. Lancet. Elsevier. 2 (7619): 501—505. PMID 4184834. doi:10.1016/S0140-6736(69)90212-8.
Cohen, M; Creaven PJ; et al. (1977). „Intensive chemotherapy of small cell bronchogenic carcinoma”. Cancer Treatment Reports. 61 (3): 349—354. PMID 194691.

profiles.nlm.nih.gov

US Department of Health Education and Welfare (1964). „Smoking and health: report of the advisory committee to the Surgeon General of the Public Health Service” (PDF). Washington, DC: US Government Printing Office.

obpr.gov.au

National Health and Medical Research Council (april 1994). „The health effects and regulation of passive smoking”. Australian Government Publishing Service. Архивирано из оригинала 29. 9. 2007. г. Приступљено 10. 8. 2007.

ojrd.com

Honnorat, J; Antoine JC (2007). „Paraneoplastic neurological syndromes”. Orphanet Journal of Rare Diseases. BioMed Central. 2 (1): 22. PMC 1868710 . PMID 17480225. doi:10.1186/1750-1172-2-22.

ox.ac.uk

ctsu.ox.ac.uk

Peto, R; Lopez AD; et al. (2006). Mortality from smoking in developed countries 1950–2000: Indirect estimates from National Vital Statistics. Oxford University Press. ISBN 978-0-19-262535-9.

oxfordjournals.org

rsnajnls.org

radiographics.rsnajnls.org

Seo, JB; Im JG; et al. (1. 3. 2001). „Atypical pulmonary metastases: spectrum of radiologic findings”. Radiographics. 21 (2): 403—417. PMID 11259704.

smokinglungs.com

Grannis, FW. „History of cigarette smoking and lung cancer”. smokinglungs.com. Архивирано из оригинала 18. 7. 2007. г. Приступљено 6. 8. 2007.

surgeongeneral.gov

Carmona, RH (27. 6. 2006). „The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General”. U.S. Department of Health and Human Services. Архивирано из оригинала 3. 7. 2006. г. Приступљено 6. 7. 2013. „Secondhand smoke exposure causes disease and premature death in children and adults who do not smoke.”

un.org

„UN health agency calls for total ban on tobacco advertising to protect young” (Саопштење). United Nations News service. 30. 5. 2008.

vpci.org.in

Behera, D; Balamugesh T (2004). „Lung cancer in India” (PDF). Indian Journal of Chest Diseases and Allied Sciences. 46 (4): 269—281. PMID 15515828. Архивирано из оригинала (PDF) 17. 12. 2008. г. Приступљено 06. 07. 2013.

web.archive.org

O'Reilly, KM; Mclaughlin AM; et al. (2007). „Asbestos-related lung disease”. American Family Physician. 75 (5): 683—688. PMID 17375514. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.
Carmona, RH (27. 6. 2006). „The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General”. U.S. Department of Health and Human Services. Архивирано из оригинала 3. 7. 2006. г. Приступљено 6. 7. 2013. „Secondhand smoke exposure causes disease and premature death in children and adults who do not smoke.”
Collins, LG; Haines C; et al. (2007). „Lung cancer: diagnosis and management”. American Family Physician. American Academy of Family Physicians. 75 (1): 56—63. PMID 17225705. Архивирано из оригинала 29. 09. 2007. г. Приступљено 06. 07. 2013.
Alberg, AJ; Samet JM (2007). „Epidemiology of lung cancer”. Chest. American College of Chest Physicians. 132 (S3): 29S—55S. PMID 17873159. doi:10.1378/chest.07-1347. Архивирано из оригинала 29. 03. 2020. г. Приступљено 08. 02. 2014.
National Health and Medical Research Council (april 1994). „The health effects and regulation of passive smoking”. Australian Government Publishing Service. Архивирано из оригинала 29. 9. 2007. г. Приступљено 10. 8. 2007.
„Frequently asked questions about second hand smoke”. World Health Organization. Архивирано из оригинала 01. 01. 2013. г. Приступљено 25. 7. 2012.
Cogliano, VJ; Baan, R; et al. (2011. 12. 21). „Preventable exposures associated with human cancers.” (PDF). Journal of the National Cancer Institute. 103 (24): 1827—39. PMID 22158127. Архивирано из оригинала (PDF) 20. 09. 2012. г. Приступљено 08. 02. 2014. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
Herbst, RS; Heymach JV; Lippman SM (2008). „Lung cancer”. New England Journal of Medicine. 359 (13): 1367—1380. PMID 18815398. doi:10.1056/NEJMra0802714. Архивирано из оригинала 28. 09. 2008. г. Приступљено 06. 07. 2013.
PORT Meta-analysis Trialists Group (2005). Rydzewska, Larysa, ур. „Postoperative radiotherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD002142. PMID 15846628. doi:10.1002/14651858.CD002142.pub2. Архивирано из оригинала 9. 2. 2010. г. Приступљено 6. 7. 2013.
Behera, D; Balamugesh T (2004). „Lung cancer in India” (PDF). Indian Journal of Chest Diseases and Allied Sciences. 46 (4): 269—281. PMID 15515828. Архивирано из оригинала (PDF) 17. 12. 2008. г. Приступљено 06. 07. 2013.
Grannis, FW. „History of cigarette smoking and lung cancer”. smokinglungs.com. Архивирано из оригинала 18. 7. 2007. г. Приступљено 6. 8. 2007.
Horn, L; Johnson DH (2008). „Evarts A. Graham and the first pneumonectomy for lung cancer”. Journal of Clinical Oncology. 26 (19): 3268—3275. PMID 18591561. doi:10.1200/JCO.2008.16.8260. Архивирано из оригинала 17. 03. 2020. г. Приступљено 06. 07. 2013.

who.int

„Frequently asked questions about second hand smoke”. World Health Organization. Архивирано из оригинала 01. 01. 2013. г. Приступљено 25. 7. 2012.
„WHO Disease and injury country estimates”. World Health Organization. 2009. Приступљено 11. 11. 2009.
„Gender in lung cancer and smoking research” (PDF). World Health Organization. 2004. Приступљено 26. 5. 2007.

wiley.com

onlinelibrary.wiley.com

Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.
Biesalski, HK; Bueno de Mesquita B; et al. (1998). „European Consensus Statement on Lung Cancer: risk factors and prevention. Lung Cancer Panel”. CA Cancer J Clin. Smoking is the major risk factor, accounting for about 90% of lung cancer incidence. 48 (3): 167—176; discussion 164—166. PMID 9594919. doi:10.3322/canjclin.48.3.167.
Ferlay, J; Shin HR; et al. (decembar 2010). „Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”. International Journal of Cancer. 127 (12): 2893—2917. PMID 21351269. doi:10.1002/ijc.25516.

mrw.interscience.wiley.com

PORT Meta-analysis Trialists Group (2005). Rydzewska, Larysa, ур. „Postoperative radiotherapy for non-small cell lung cancer”. Cochrane Database of Systematic Reviews (2): CD002142. PMID 15846628. doi:10.1002/14651858.CD002142.pub2. Архивирано из оригинала 9. 2. 2010. г. Приступљено 6. 7. 2013.

worldcat.org

British Medical Journal (2005). Clinical evidence concise : the international resource of the best available evidence for effective health care. London: BMJ Publishing Group. стр. 486-488. ISBN 978-1-905545-00-1. ISSN 1475-9225.
Adler, I (1912). Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green, and Company. OCLC 14783544. , navedeno u Spiro SG, Silvestri GA (2005). „One hundred years of lung cancer”. American Journal of Respiratory and Critical Care Medicine. 172 (5): 523—529. PMID 15961694. doi:10.1164/rccm.200504-531OE.

Rak pluća (Serbian Wikipedia)

aafp.org

archive.org

ascopubs.org

jco.ascopubs.org

atcs.jp

atsjournals.org

ajrccm.atsjournals.org

bbc.co.uk

news.bbc.co.uk

bmj.com

tobaccocontrol.bmj.com

cancer.gov

seer.cancer.gov

cancer.gov

cdc.gov

chestpubs.org

chestjournal.chestpubs.org

doi.org

druglibrary.org

epa.gov

ersjournals.com

erj.ersjournals.com

google.ca

books.google.ca

iarc.fr

monographs.iarc.fr

jst.go.jp

jstage.jst.go.jp

merck.com

nature.com

nejm.org

content.nejm.org

nih.gov

ncbi.nlm.nih.gov

profiles.nlm.nih.gov

obpr.gov.au

ojrd.com

ox.ac.uk

ctsu.ox.ac.uk

oxfordjournals.org

ije.oxfordjournals.org

annonc.oxfordjournals.org

toxsci.oxfordjournals.org

rsnajnls.org

radiographics.rsnajnls.org

smokinglungs.com

surgeongeneral.gov

un.org

vpci.org.in

web.archive.org

who.int

wiley.com

onlinelibrary.wiley.com

mrw.interscience.wiley.com

worldcat.org